HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiangjian Zhang Selected Research

ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylate

6/2022Hydrogen sulfide ameliorated preeclampsia via suppression of toll-like receptor 4-activated inflammation in the rostral ventrolateral medulla of rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiangjian Zhang Research Topics

Disease

37Infarction (Infarctions)
07/2022 - 07/2009
37Brain Ischemia (Cerebral Ischemia)
07/2022 - 07/2009
31Ischemic Stroke
07/2022 - 04/2010
25Stroke (Strokes)
07/2022 - 03/2010
21Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2021 - 08/2009
12Inflammation (Inflammations)
06/2022 - 01/2012
12Reperfusion Injury
01/2020 - 08/2009
12Ischemia
05/2018 - 01/2009
7Neoplasms (Cancer)
01/2022 - 10/2012
6Alzheimer Disease (Alzheimer's Disease)
01/2021 - 06/2012
5Hypoxia (Hypoxemia)
01/2021 - 08/2014
5Cerebral Infarction
01/2020 - 03/2015
5Brain Edema (Cerebral Edema)
10/2019 - 12/2006
5Edema (Dropsy)
01/2014 - 01/2011
4Neuroinflammatory Diseases
11/2022 - 12/2019
3Neoplasm Metastasis (Metastasis)
01/2022 - 11/2017
3Brain Injuries (Brain Injury)
09/2012 - 01/2009
2Overweight
01/2022 - 09/2020
2Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2018
2Hypoventilation
09/2020 - 01/2018
2Obesity
09/2020 - 01/2018
2Hypercapnia
09/2020 - 01/2018
2Hypertension (High Blood Pressure)
02/2019 - 01/2019
2Pancreatitis
04/2017 - 09/2012
2Atherosclerosis
10/2015 - 01/2013
2Rheumatoid Arthritis
06/2012 - 04/2012
1Pre-Eclampsia (Preeclampsia)
06/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1COVID-19
10/2021
1Disease Progression
10/2021
1Pulmonary Embolism
06/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2021

Drug/Important Bio-Agent (IBA)

14Neuroprotective AgentsIBA
11/2021 - 05/2010
10salicylhydroxamic acid (SHAM)IBA
11/2021 - 09/2012
9Claudin-5IBA
08/2014 - 03/2010
8Biological ProductsIBA
08/2014 - 04/2012
6NF-kappa B (NF-kB)IBA
04/2017 - 01/2009
6AntioxidantsIBA
04/2016 - 01/2011
5CytokinesIBA
01/2022 - 12/2006
5Pharmaceutical PreparationsIBA
11/2019 - 01/2013
5Transcription Factors (Transcription Factor)IBA
01/2014 - 07/2009
4Atorvastatin (Lipitor)FDA Link
01/2021 - 03/2010
4oxymatrineIBA
01/2021 - 01/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019 - 12/2006
4Therapeutic UsesIBA
10/2015 - 01/2013
3Bromodeoxyuridine (BrdU)IBA
07/2022 - 10/2017
3Glucagon-Like Peptide 1 (GLP 1)IBA
07/2022 - 01/2018
3Toll-Like Receptor 4IBA
06/2022 - 10/2015
3Antihypertensive Agents (Antihypertensives)IBA
01/2021 - 09/2016
3Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2010
3LipidsIBA
11/2019 - 12/2014
3AcidsIBA
01/2019 - 10/2017
3Saline SolutionIBA
05/2018 - 08/2014
3Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2017 - 05/2010
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2022 - 01/2018
2LiraglutideFDA Link
07/2022 - 05/2018
2Mitogen-Activated Protein KinasesIBA
01/2022 - 04/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 03/2015
2Eosine Yellowish-(YS) (Eosin)IBA
01/2021 - 01/2021
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2018
2Hematoxylin (Haematoxylon)IBA
01/2021 - 01/2021
23-n-butylphthalide (butylphthalide)IBA
01/2021 - 10/2019
2LeptinIBA
09/2020 - 01/2018
2CateninsIBA
12/2019 - 10/2012
2p38 Mitogen-Activated Protein KinasesIBA
11/2019 - 10/2010
2Heme Oxygenase-1IBA
11/2019 - 06/2016
2Small Interfering RNA (siRNA)IBA
01/2019 - 11/2017
2oxidized low density lipoproteinIBA
09/2018 - 01/2016
2nobiletinIBA
04/2016 - 07/2013
2Polysorbates (PSML)FDA Link
04/2016 - 07/2013
2Stem Cell FactorIBA
01/2015 - 01/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2015 - 01/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2014 - 03/2010
2Carboxymethylcellulose Sodium (Polycell)FDA Link
01/2014 - 08/2013
2bicyclolIBA
01/2014 - 08/2013
2TNF Receptor-Associated Factor 6 (TRAF6)IBA
08/2013 - 07/2012
2LuteolinIBA
09/2012 - 04/2012
2tanshinoneIBA
05/2010 - 03/2010
2HMGB1 Protein (HMG1)IBA
03/2010 - 03/2010
1Thioctic Acid (Lipoic Acid)IBA
11/2022
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
07/2022
1LipopolysaccharidesIBA
06/2022
1ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
06/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
06/2022
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
06/2022
1sodium bisulfide (NaHS)IBA
06/2022
1Ferritins (Ferritin)IBA
01/2022
1IronIBA
01/2022
1fisogatinibIBA
01/2022
1C-Reactive ProteinIBA
01/2022
1BilirubinIBA
01/2022
1Alkaline PhosphataseIBA
01/2022
1Type 4 Fibroblast Growth Factor ReceptorIBA
01/2022
1AlbuminsIBA
01/2022
1ArtesunateIBA
11/2021
1Gefitinib (Iressa)FDA Link
06/2021
1DabigatranFDA Link
06/2021

Therapy/Procedure

11Therapeutics
10/2021 - 01/2011
2Intraperitoneal Injections
01/2020 - 11/2017